The purpose of this study is to compare the usual treatment of Azacitidine and Venetoclax to the combination treatment of Azacitidine, Venetoclax, and Gilteritinib.

Learn more about the MyeloMATCH MM1OA-EA02 trial or call the Reading Hospital Cancer Research Office at 484-628-8193.

Location

Reading Hospital
Hospital

Reading Hospital

Reading Hospital is the flagship, Magnet Recognized, acute care hospital of Tower Health. Located in West Reading, Pennsylvania, Reading Hospital is a 697-bed hospital that is home to many top-tier specialty care centers.

Address 420 South 5th Avenue West Reading, PA 19611
Phone (484)628-8000